Indian pharma sales hit ₹70,180 crore, up 12% YoY, driven by chronic care demand and consolidation among large, compliant manufacturers. The domestic pharmaceutical industry has maintained a steady growth trajectory, recording a 12% year-on-year increase in the September 2026 quarter with total sales reaching ₹70,180 crore. This marks the fourth consecutive quarter of double-digit expansion, a significant shift from the 6%-8% growth trends seen throughout 2025.